Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 30, 2019 Off

X-Biotix Therapeutics, Inc. Strengthens Leadership Team with Key Appointments

By BusinessWire

Announces Additions of Dr. David N. Cook to Board of Directors and Dr. Boudewijn DeJonge to Leadership Team WALTHAM, Mass.–(BUSINESS…

May 30, 2019 Off

Antibe Therapeutics Announces Upcoming Conference Schedule

By BusinessWire

TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain…

May 30, 2019 Off

Acerus Signs License Agreement to Nasal Technology with University of Texas at Austin

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or “the Company”) (TSX:ASP; OTCQB:ASPCF) announced today that it has signed a patent license agreement (the…

May 30, 2019 Off

Acerus Signs License Agreement to Nasal Technology with University of Texas at Austin

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or “the Company”) (TSX:ASP; OTCQB:ASPCF) announced today that it has signed a patent license agreement (the…

May 30, 2019 Off

F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019

By BusinessWire

Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…

May 30, 2019 Off

F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019

By BusinessWire

Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…

May 30, 2019 Off

Pharmaceuticals Partnerships, Licensing, Investments, and M&A Deals & Trends (Feb, 2019) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report has been added to…

May 30, 2019 Off

Pharmaceuticals Partnerships, Licensing, Investments, and M&A Deals & Trends (Feb, 2019) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report has been added to…

May 30, 2019 Off

Epizyme Submits New Drug Application to the U.S. FDA for Tazemetostat for the Treatment of Patients with Epithelioid Sarcoma

By BusinessWire

Submission Follows Productive Pre-NDA Meeting and Marks On-time Execution of First of Two NDA Submissions Planned for 2019 CAMBRIDGE, Mass.–(BUSINESS…

May 30, 2019 Off

The Global Pain Therapeutics Market, 2019: GPCR & Nerve Growth Factor-based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes” report has been added to…

Posts pagination

Previous 1 … 3,152 3,153 3,154 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine